A phase 1/2 randomized, double-blinded, placebo controlled ascending dose trial to assess the safety, tolerability and immunogenicity of ARCT-021 in healthy adults

Jenny G. Low; Ruklanthi de Alwis; Shiwei Chen; Shirin Kalimuddin; Yan Shan Leong; Tania Ken Lin Mah; Natalene Yuen; Hwee Cheng Tan; Summer L Zhang; Jean X.Y. Sim; Yvonne F.Z. Chan; Ayesa Syenina; Jia Xin Yee; Eugenia Z. Ong; Rose Sekulovich; Brian B. Sullivan; Kelly Lindert; Sean B. Sullivan; Pad Chivukula; Steven G. Hughes; Eng Eong. Ooi

bioRxiv (2021) - Comments
doi: 10.1101/2021.07.01.21259831

Jenny G. Low, Ruklanthi De Alwis, Shiwei Chen, Shirin Kalimuddin, Yan Shan Leong, Tania Ken Lin Mah, Natalene Yuen, Hwee Cheng Tan, Summer L Zhang, Jean X.Y. Sim, Yvonne F.Z. Chan, Ayesa Syenina, Jia Xin Yee, Eugenia Z. Ong, Rose Sekulovich, Brian B. Sullivan, Kelly Lindert, Sean B. Sullivan, Pad Chivukula, Steven G. Hughes